Tatsuaki Yoneda

Seirei Hamamatsu General Hospital

Papers

17

Total Citations

84

H-Index

5

About

Dr. Tatsuaki Yoneda is a leading Japanese urologic oncologist whose research focuses on optimizing surgical and oncological outcomes for prostate cancer patients undergoing robot-assisted radical prostatectomy (RARP). As a key member of the MSUG94 multicenter study group, Dr. Yoneda has made substantial contributions to understanding the role of pelvic lymph node dissection (PLND), demonstrating that it may not improve biochemical recurrence-free survival in Japanese patients. Their work has also clarified the prognostic significance of lymphovascular invasion, positive surgical margin locations, and seminal vesicle involvement, providing surgeons with critical insights for risk stratification. Dr. Yoneda developed a novel nomogram for predicting lymph node involvement in the RARP era and investigated the impact of hospital volume on surgical outcomes. With over 70 cumulative citations, their research has helped refine surgical decision-making and postoperative management. Notably, their studies on inguinal hernia incidence after RARP and the negative impact of inflammation-related parameters have expanded the understanding of long-term complications and systemic factors in prostate cancer prognosis. Dr. Yoneda’s work continues to shape evidence-based practice in robotic prostate surgery.

Research Focus

Key Achievements

5
H-Index
17
Papers
84
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Pelvic Lymphadenectomy May Not Improve Biochemical Recurrence-Free Survival in Patients with Prostate Cancer Treated with Robot-Assisted Radical Prostatectomy in Japan (The MSUG94 Group)
15 citations · 2022
📈 Most Prolific Year: 2023 (6 Papers)
🤝 Key Collaborators: 40
🏛 Institutions: Seirei Hamamatsu General Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago